4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018319
Director acquired 3,339,137 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BYERS BLAKE Director | 2018-06-25 | Conversion | +3,339,137 | 3,339,137 | I | ||
| Derivatives | |||||||
| BYERS BLAKE Director | 2018-06-25 | Conversion · Series A Preferred Stock | −133,400 | 0 | I | ||
| BYERS BLAKE Director | 2018-06-25 | Conversion · Series B Preferred Stock | −8,494,864 | 0 | I | ||
Loading xslF345X03/doc4.xml…